XBKK
KDH
Market cap47mUSD
Nov 06, Last price
83.00THB
Name
Thonburi Medical Centre PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Thonburi Medical Centre Public Company Limited, established in 1977 and headquartered in Bangkok, Thailand, is a prominent healthcare provider operating hospitals throughout the country. The company delivers a broad spectrum of medical and aesthetic services, including treatments for hair loss, comprehensive weight management, sexual wellness, facial enhancements, and cosmetic surgery. Additionally, it offers specialized services for promoting hair growth in areas such as eyebrows, mustaches, beards, and sideburns. The organization was formerly recognized as Krungdhon Hospital Public Company Limited until its rebranding in April 2013.
Key people
Chayan Sunthornnon
Vice Chairman of the Executive Board, Director, Independent Director · since 2010
Chakraphan Sukhaphanphottharam
Chief Executive Officer, Vice President, Director · since 2009
Dusadi Chuengyaempin
Managing Director of Services · since 2011
Malai Mahamaneerat
Managing Director · since 2013
Managing Director, Director · since 2019
Anchali Sahakitphicharn
Managing Director of Hospital, Executive Director, Director · since 2010
Salai Sukhaphanphottharam
Chairman of the Executive Board, Managing Director, Director
Chanthrakarn Thammongkhon
Managing Director, Executive Director
Phutwan Phornprasoetsuk
Executive Director
Surachet Suphanit
Managing Director of Hospital, Executive Director, Director
Tippanuch Jenpunyarat
Secretary · since 2013
Niwat Chikangwan
Managing Director, Director · since 2018
Chumsak Pruksaphong
Director · since 2017
Chairman of the Board · since 2013
Director · since 2013
Wannapa Wannapa
Director · since 2013
Kessara Wongket
Director · since 2013
Kittisak Benchalit
Independent Director · since 2013
Jumphot Chuasai
Independent Director · since 2021
Kittiphan Kanchanaphiphatkun
Independent Director · since 2010
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||